Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Psychiatry Research|July 1, 1993
Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatmentS C Pandey, R P Sharma, P G Janicak, et al.Psychopharmacology|January 1, 1985
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophreniaS S Chang, J I Javaid, M W Dysken, et al.Applied Ergonomics|March 6, 2019
Camouflage pattern features interact with movement speed to determine human target detectabilityTad T Brunyé, Shaina B Martis, John A Kirejczyk, et al.Journal of Forensic Sciences|September 25, 2001
Deposition of 7-aminoflunitrazepam and flunitrazepam in hair after a single dose of RohypnolA Negrusz, C M Moore, K B Hinkel, et al.Applied Ergonomics|August 13, 2018
Visual salience and biological motion interact to determine camouflaged target detectabilityTad T Brunyé, Shaina B Martis, Carlene Horner, et al.Journal of Psychiatric Research|October 10, 2001
CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disordersR P Sharma, B Martis, C Rosen, et al.The Journal of Clinical Psychiatry|February 1, 1990
MAO inhibition and clinical response in depressed patients treated with phenelzineD B Bresnahan, G N Pandey, P G Janicak, et al.Psychiatry Research|December 1, 1983
Relatives of unipolar and bipolar patients have normal pursuitD L Levy, N J Yasillo, E Dorus, et al.Archives of General Psychiatry|April 1, 1985
Pharmacologic evidence for specificity of pursuit dysfunction to schizophrenia. Lithium carbonate associated with abnormal pursuitD L Levy, E Dorus, R Shaughnessy, et al.Journal of Clinical Psychopharmacology|July 31, 2001
A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorderP G Janicak, P E Keck, J M Davis, et al.Pageof 7